只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 2026-07-30 2026-07-31 | ACAD ACADIA PHARMACEUTICALS INC | Thompson Elizabeth H.Z. Officer · EVP, Head of Research & Dev | 卖出（S） | 16,508 | US$26.13 | US$431,354.04 | 19,044 | SEC |
| 2026-07-30 2026-07-31 | ACAD ACADIA PHARMACEUTICALS INC | Thompson Elizabeth H.Z. Officer · EVP, Head of Research & Dev | 卖出（S） | 50 | US$26.17 | US$1,308.50 | 18,994 | SEC |
| 2026-07-29 2026-07-31 | KNSA Kiniksa Pharmaceuticals International, plc | Cole G Bradley Director | 卖出（S） | 3,673 | US$81.43 | US$299,092.39 | 11,672 | SEC |
| 2026-07-29 2026-07-30 | ANIP ANI PHARMACEUTICALS INC | CAREY STEPHEN P. Officer · SVP & CFO | 卖出（S） | 2,850 | US$81.36 | US$231,876.00 | 174,693 | SEC |
| 2026-07-28 2026-07-29 | LUNR Intuitive Machines, Inc. | ADVENT INTERNATIONAL, L.P. TenPercentOwner | 卖出（S） | 11,495,514 | US$12.84 | US$1.48亿 | 11,495,514 | SEC |
| 2026-07-28 2026-07-29 | LUNR Intuitive Machines, Inc. | ADVENT INTERNATIONAL GP, LLC TenPercentOwner | 卖出（S） | 11,495,514 | US$12.84 | US$1.48亿 | 11,495,514 | SEC |
| 2026-07-28 2026-07-29 | LUNR Intuitive Machines, Inc. | Galileo TopCo, Inc. TenPercentOwner | 卖出（S） | 11,495,514 | US$12.84 | US$1.48亿 | 11,495,514 | SEC |
| 2026-07-27 2026-07-29 | LUNR Intuitive Machines, Inc. | Ghaffarian Kamal Seyed Director,TenPercentOwner | 卖出（S） | 47,303 | US$13.20 | US$624,404.33 | 3,494,768 | SEC |
| 2026-07-27 2026-07-29 | LUNR Intuitive Machines, Inc. | Ghaffarian Enterprises, LLC TenPercentOwner | 卖出（S） | 47,303 | US$13.20 | US$624,404.33 | 3,494,768 | SEC |
| 2026-07-27 2026-07-29 | LUNR Intuitive Machines, Inc. | GM Enterprises, LLC TenPercentOwner | 卖出（S） | 47,303 | US$13.20 | US$624,404.33 | 3,494,768 | SEC |
| 2026-07-24 2026-07-28 | ORIC Oric Pharmaceuticals, Inc. | Heyman Richard A. Director | 卖出（S） | 7,000 | US$12.02 | US$84,140.00 | 38,300 | SEC |
| 2026-07-24 2026-07-28 | ORIC Oric Pharmaceuticals, Inc. | Heyman Richard A. Director | 卖出（S） | 6,100 | US$12.02 | US$73,322.00 | 206,672 | SEC |
| 2026-07-24 2026-07-27 | OLMA Olema Pharmaceuticals, Inc. | Harmon Cyrus Director | 卖出（S） | 12,500 | US$11.71 | US$146,425.00 | 702,770 | SEC |
| 2026-07-23 2026-07-27 | OLMA Olema Pharmaceuticals, Inc. | Harmon Cyrus Director | 卖出（S） | 12,500 | US$11.58 | US$144,737.50 | 715,270 | SEC |
| 2026-07-21 2026-07-22 | PLMR Palomar Holdings, Inc. | Armstrong Mac Director,Officer · CEO and Chairman | 卖出（S） | 2,103 | US$136.70 | US$287,476.52 | 327,285 | SEC |
| 2026-07-21 2026-07-22 | PLMR Palomar Holdings, Inc. | Armstrong Mac Director,Officer · CEO and Chairman | 卖出（S） | 937 | US$137.74 | US$129,060.69 | 326,348 | SEC |
| 2026-07-21 2026-07-22 | PLMR Palomar Holdings, Inc. | Armstrong Mac Director,Officer · CEO and Chairman | 卖出（S） | 260 | US$138.47 | US$36,001.11 | 326,088 | SEC |
| 2026-07-21 2026-07-22 | PLMR Palomar Holdings, Inc. | Armstrong Mac Director,Officer · CEO and Chairman | 卖出（S） | 200 | US$139.43 | US$27,886.00 | 325,888 | SEC |
| 2026-07-20 2026-07-20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John Director,Officer · President and CEO | 卖出（S） | 140 | US$542.75 | US$75,984.43 | 211,689 | SEC |
| 2026-07-20 2026-07-20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John Director,Officer · President and CEO | 卖出（S） | 280 | US$555.05 | US$155,414.00 | 209,329 | SEC |
| 2026-07-20 2026-07-20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John Director,Officer · President and CEO | 卖出（S） | 110 | US$543.79 | US$59,817.22 | 211,579 | SEC |
| 2026-07-20 2026-07-20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John Director,Officer · President and CEO | 卖出（S） | 545 | US$544.71 | US$296,869.13 | 211,034 | SEC |
| 2026-07-20 2026-07-20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John Director,Officer · President and CEO | 卖出（S） | 275 | US$545.71 | US$150,070.03 | 210,759 | SEC |
| 2026-07-20 2026-07-20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John Director,Officer · President and CEO | 卖出（S） | 269 | US$547.08 | US$147,164.20 | 210,490 | SEC |
| 2026-07-20 2026-07-20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John Director,Officer · President and CEO | 卖出（S） | 680 | US$547.70 | US$372,434.64 | 209,810 | SEC |
| 2026-07-20 2026-07-20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John Director,Officer · President and CEO | 卖出（S） | 47 | US$548.87 | US$25,796.98 | 209,763 | SEC |
| 2026-07-20 2026-07-20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John Director,Officer · President and CEO | 卖出（S） | 153 | US$550.01 | US$84,152.11 | 209,610 | SEC |
| 2026-07-20 2026-07-20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John Director,Officer · President and CEO | 卖出（S） | 1 | US$550.72 | US$550.72 | 209,609 | SEC |
| 2026-07-16 2026-07-16 | ADIL ADIAL PHARMACEUTICALS, INC. | Coastlands Capital LP TenPercentOwner | 买入（P） | 1,233 | US$2.75 | US$3,390.75 | 388,308 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 19 | US$1.55 | US$29.45 | 743,057 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 19 | US$1.55 | US$29.45 | 743,057 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 19 | US$1.55 | US$29.45 | 743,057 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 19 | US$1.55 | US$29.45 | 743,057 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 2 | US$1.55 | US$3.10 | 75,019 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 2 | US$1.55 | US$3.10 | 75,019 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 2 | US$1.55 | US$3.10 | 75,019 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 2 | US$1.55 | US$3.10 | 75,019 | SEC |
| 2026-07-15 2026-07-17 | PLMR Palomar Holdings, Inc. | Armstrong Mac Director,Officer · CEO and Chairman | 卖出（S） | 3,197 | US$131.66 | US$420,917.02 | 105,112 | SEC |
| 2026-07-15 2026-07-17 | PLMR Palomar Holdings, Inc. | Armstrong Mac Director,Officer · CEO and Chairman | 卖出（S） | 57,544 | US$131.66 | US$757.62万 | 160,068 | SEC |
| 2026-07-15 2026-07-17 | INM InMed Pharmaceuticals Inc. | ADAR1 Capital Management, LLC TenPercentOwner | 买入（P） | 1,000 | US$1.56 | US$1,555.00 | 801,000 | SEC |
| 2026-07-15 2026-07-17 | INM InMed Pharmaceuticals Inc. | Schneeberger Daniel TenPercentOwner | 买入（P） | 1,000 | US$1.56 | US$1,555.00 | 801,000 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 13,761 | US$1.55 | US$21,329.55 | 743,038 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 13,761 | US$1.55 | US$21,329.55 | 743,038 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 13,761 | US$1.55 | US$21,329.55 | 743,038 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 13,761 | US$1.55 | US$21,329.55 | 743,038 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 1,389 | US$1.55 | US$2,152.95 | 75,017 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 1,389 | US$1.55 | US$2,152.95 | 75,017 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 1,389 | US$1.55 | US$2,152.95 | 75,017 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 1,389 | US$1.55 | US$2,152.95 | 75,017 | SEC |
| 2026-07-14 2026-07-16 | ADIL ADIAL PHARMACEUTICALS, INC. | Coastlands Capital LP TenPercentOwner | 买入（P） | 2,000 | US$2.65 | US$5,300.00 | 387,075 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 4,882 | US$1.55 | US$7,567.10 | 729,277 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 4,882 | US$1.55 | US$7,567.10 | 729,277 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 4,882 | US$1.55 | US$7,567.10 | 729,277 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 4,882 | US$1.55 | US$7,567.10 | 729,277 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 493 | US$1.55 | US$764.15 | 73,628 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 493 | US$1.55 | US$764.15 | 73,628 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 493 | US$1.55 | US$764.15 | 73,628 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 493 | US$1.55 | US$764.15 | 73,628 | SEC |
| 2026-07-14 2026-07-16 | ETON Eton Pharmaceuticals, Inc. | Opaleye Management Inc. TenPercentOwner | 卖出（S） | 15,000 | US$37.54 | US$563,146.50 | 2,665,000 | SEC |
| 2026-07-14 2026-07-16 | ETON Eton Pharmaceuticals, Inc. | Opaleye Management Inc. TenPercentOwner | 卖出（S） | 13,315 | US$37.54 | US$499,886.38 | 40,000 | SEC |
| 2026-07-14 2026-07-15 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | HRT FINANCIAL LP TenPercentOwner | 卖出（S） | 82,116 | US$4.48 | US$367,879.68 | 0 | SEC |
| 2026-07-13 2026-07-15 | LUNR Intuitive Machines, Inc. | Ghaffarian Kamal Seyed Director,TenPercentOwner | 卖出（S） | 110,976 | US$15.64 | US$173.57万 | 3,494,768 | SEC |
| 2026-07-13 2026-07-15 | LUNR Intuitive Machines, Inc. | Ghaffarian Enterprises, LLC TenPercentOwner | 卖出（S） | 110,976 | US$15.64 | US$173.57万 | 3,494,768 | SEC |
| 2026-07-13 2026-07-15 | LUNR Intuitive Machines, Inc. | GM Enterprises, LLC TenPercentOwner | 卖出（S） | 110,976 | US$15.64 | US$173.57万 | 3,494,768 | SEC |
| 2026-07-13 2026-07-15 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | HRT FINANCIAL LP TenPercentOwner | 卖出（S） | 1,033 | US$4.67 | US$4,824.11 | 60,238 | SEC |
| 2026-07-13 2026-07-14 | ANIP ANI PHARMACEUTICALS INC | Cook Meredith Officer · SR. VP, GENERAL COUNSEL & SEC. | 卖出（S） | 500 | US$81.84 | US$40,920.00 | 77,390 | SEC |
| 2026-07-10 2026-07-13 | ADIL ADIAL PHARMACEUTICALS, INC. | Coastlands Capital LP TenPercentOwner | 买入（P） | 1,700 | US$2.70 | US$4,590.00 | 385,075 | SEC |
| 2026-07-10 2026-07-13 | AMLX Amylyx Pharmaceuticals, Inc. | Mazzariello Gina Officer · Chief Legal Officer | 卖出（S） | 15,000 | US$17.61 | US$264,121.50 | 179,090 | SEC |
| 2026-07-10 2026-07-13 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | HRT FINANCIAL LP TenPercentOwner | 买入（P） | 731 | US$3.11 | US$2,273.41 | 61,271 | SEC |
| 2026-07-10 2026-07-13 | INDV Indivior Pharmaceuticals, Inc. | Heidbreder Christian Officer · Chief Scientific Officer | 卖出（S） | 18,586 | US$41.14 | US$764,628.04 | 209,337 | SEC |
| 2026-07-09 2026-07-13 | ADIL ADIAL PHARMACEUTICALS, INC. | Coastlands Capital LP TenPercentOwner | 买入（P） | 10,053 | US$2.79 | US$28,047.87 | 383,375 | SEC |
| 2026-07-09 2026-07-13 | AMLX Amylyx Pharmaceuticals, Inc. | Mazzariello Gina Officer · Chief Legal Officer | 卖出（S） | 15,000 | US$18.32 | US$274,746.00 | 194,090 | SEC |
| 2026-07-09 2026-07-13 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | HRT FINANCIAL LP TenPercentOwner | 买入（P） | 8,266 | US$3.38 | US$27,939.08 | 60,540 | SEC |
| 2026-07-08 2026-07-09 | SNDX Syndax Pharmaceuticals Inc | Metzger Michael A Director,Officer · Chief Executive Officer | 卖出（S） | 32,375 | US$24.24 | US$784,776.48 | 484,843 | SEC |
| 2026-07-08 2026-07-09 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | HRT FINANCIAL LP TenPercentOwner | 卖出（S） | 18,531 | US$3.52 | US$65,229.12 | 52,274 | SEC |
| 2026-07-07 2026-07-09 | IONS IONIS PHARMACEUTICALS INC | Kordasiewicz Holly B. Officer · EVP, Chief Development Officer | 卖出（S） | 362 | US$84.30 | US$30,516.60 | 22,096 | SEC |
| 2026-07-07 2026-07-09 | IONS IONIS PHARMACEUTICALS INC | Diaz Allene M. Director | 卖出（S） | 10,111 | US$85.42 | US$863,637.13 | 3,811 | SEC |
| 2026-07-07 2026-07-09 | IONS IONIS PHARMACEUTICALS INC | BENNETT C FRANK Officer · EVP, Chief Scientific Officer | 卖出（S） | 5,536 | US$83.58 | US$462,693.34 | 75,018 | SEC |
| 2026-07-07 2026-07-09 | IONS IONIS PHARMACEUTICALS INC | BENNETT C FRANK Officer · EVP, Chief Scientific Officer | 卖出（S） | 15,000 | US$85.46 | US$128.19万 | 0 | SEC |
| 2026-07-07 2026-07-09 | IRWD IRONWOOD PHARMACEUTICALS INC | Silver Ronald Officer · PFO & PAO | 卖出（S） | 127,890 | US$4.52 | US$578,062.80 | 313,680 | SEC |
| 2026-07-07 2026-07-09 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | HRT FINANCIAL LP TenPercentOwner | 卖出（S） | 10,580 | US$3.33 | US$35,231.40 | 70,805 | SEC |
| 2026-07-07 2026-07-09 | RXRX RECURSION PHARMACEUTICALS, INC. | Borgeson Blake Director | 卖出（S） | 40,000 | US$3.96 | US$158,500.00 | 6,218,287 | SEC |
| 2026-07-07 2026-07-07 | ETON Eton Pharmaceuticals, Inc. | Opaleye Management Inc. TenPercentOwner | 卖出（S） | 20,000 | US$38.37 | US$767,456.00 | 2,680,000 | SEC |
| 2026-07-07 2026-07-07 | ETON Eton Pharmaceuticals, Inc. | Opaleye Management Inc. TenPercentOwner | 卖出（S） | 6,685 | US$38.37 | US$256,522.17 | 53,315 | SEC |
| 2026-07-06 2026-07-08 | MIRM Mirum Pharmaceuticals, Inc. | BJERKHOLT ERIC Officer · CHIEF FINANCIAL OFFICER | 卖出（S） | 3,124 | US$121.67 | US$380,097.08 | 44,057 | SEC |
| 2026-07-06 2026-07-08 | MIRM Mirum Pharmaceuticals, Inc. | BJERKHOLT ERIC Officer · CHIEF FINANCIAL OFFICER | 卖出（S） | 1,048 | US$122.43 | US$128,306.64 | 43,009 | SEC |
| 2026-07-06 2026-07-08 | MIRM Mirum Pharmaceuticals, Inc. | BJERKHOLT ERIC Officer · CHIEF FINANCIAL OFFICER | 卖出（S） | 528 | US$123.84 | US$65,387.52 | 42,481 | SEC |
| 2026-07-06 2026-07-08 | MIRM Mirum Pharmaceuticals, Inc. | BJERKHOLT ERIC Officer · CHIEF FINANCIAL OFFICER | 卖出（S） | 300 | US$124.94 | US$37,482.00 | 42,181 | SEC |
| 2026-07-06 2026-07-08 | ORIC Oric Pharmaceuticals, Inc. | Heyman Richard A. Director | 卖出（S） | 300 | US$12.00 | US$3,600.00 | 212,772 | SEC |
| 2026-07-06 2026-07-08 | MIRM Mirum Pharmaceuticals, Inc. | Peetz Christopher Director,Officer · CHIEF EXECUTIVE OFFICER | 卖出（S） | 12,134 | US$121.65 | US$147.61万 | 202,175 | SEC |
| 2026-07-06 2026-07-08 | MIRM Mirum Pharmaceuticals, Inc. | Peetz Christopher Director,Officer · CHIEF EXECUTIVE OFFICER | 卖出（S） | 4,181 | US$122.34 | US$511,503.54 | 197,994 | SEC |
| 2026-07-06 2026-07-08 | MIRM Mirum Pharmaceuticals, Inc. | Peetz Christopher Director,Officer · CHIEF EXECUTIVE OFFICER | 卖出（S） | 1,975 | US$123.74 | US$244,386.50 | 196,019 | SEC |
| 2026-07-06 2026-07-08 | MIRM Mirum Pharmaceuticals, Inc. | Peetz Christopher Director,Officer · CHIEF EXECUTIVE OFFICER | 卖出（S） | 1,710 | US$124.79 | US$213,390.90 | 194,309 | SEC |
| 2026-07-06 2026-07-07 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | HRT FINANCIAL LP TenPercentOwner | 卖出（S） | 9,022 | US$3.51 | US$31,667.22 | 81,385 | SEC |
| 2026-07-06 2026-07-07 | ETON Eton Pharmaceuticals, Inc. | Opaleye Management Inc. TenPercentOwner | 卖出（S） | 10,000 | US$38.00 | US$380,000.00 | 2,700,000 | SEC |
| 2026-07-02 2026-07-07 | VRTX VERTEX PHARMACEUTICALS INC / MA | McKechnie Duncan Officer · EVP, Chief Commercial Officer | 卖出（S） | 1,541 | US$519.00 | US$799,779.00 | 11,001 | SEC |
| 2026-07-02 2026-07-07 | VRTX VERTEX PHARMACEUTICALS INC / MA | Tatsis Ourania Officer · EVP, Chief Reg. & Quality Off. | 卖出（S） | 1,500 | US$524.99 | US$787,485.00 | 45,321 | SEC |
| 2026-07-02 2026-07-07 | REGN REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F Director | 卖出（S） | 200 | US$650.15 | US$130,030.00 | 17,303 | SEC |
| 2026-07-02 2026-07-07 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | HRT FINANCIAL LP TenPercentOwner | 买入（P） | 7,851 | US$3.54 | US$27,792.54 | 90,407 | SEC |
| 2026-07-02 2026-07-07 | ETON Eton Pharmaceuticals, Inc. | Opaleye Management Inc. TenPercentOwner | 卖出（S） | 65,000 | US$37.39 | US$243万 | 2,710,000 | SEC |
| 2026-07-02 2026-07-07 | ETON Eton Pharmaceuticals, Inc. | Opaleye Management Inc. TenPercentOwner | 卖出（S） | 25,000 | US$37.39 | US$934,627.50 | 60,000 | SEC |
| 2026-07-02 2026-07-07 | CRNX Crinetics Pharmaceuticals, Inc. | Vivaldi Coelho Rogerio Director | 卖出（S） | 3,000 | US$40.00 | US$120,000.00 | 19,225 | SEC |
| 2026-07-02 2026-07-06 | ANIP ANI PHARMACEUTICALS INC | CAREY STEPHEN P. Officer · SVP & CFO | 卖出（S） | 3,313 | US$86.00 | US$284,918.00 | 177,543 | SEC |
| 2026-07-02 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 1,460 | US$1.55 | US$2,263.00 | 724,395 | SEC |
| 2026-07-02 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 1,460 | US$1.55 | US$2,263.00 | 724,395 | SEC |
| 2026-07-02 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 1,460 | US$1.55 | US$2,263.00 | 724,395 | SEC |
| 2026-07-02 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 1,460 | US$1.55 | US$2,263.00 | 724,395 | SEC |
| 2026-07-02 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 147 | US$1.55 | US$227.85 | 73,135 | SEC |
| 2026-07-02 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 147 | US$1.55 | US$227.85 | 73,135 | SEC |
| 2026-07-02 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 147 | US$1.55 | US$227.85 | 73,135 | SEC |
| 2026-07-02 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 147 | US$1.55 | US$227.85 | 73,135 | SEC |
| 2026-07-01 2026-07-06 | IONS IONIS PHARMACEUTICALS INC | KLEIN JOSEPH III Director | 卖出（S） | 99 | US$79.45 | US$7,865.55 | 22,433 | SEC |
| 2026-07-01 2026-07-06 | IONS IONIS PHARMACEUTICALS INC | KLEIN JOSEPH III Director | 卖出（S） | 11,419 | US$79.04 | US$902,550.91 | 11,014 | SEC |
| 2026-07-01 2026-07-06 | VRTX VERTEX PHARMACEUTICALS INC / MA | Liu Joy Officer · EVP and Chief Legal Officer | 卖出（S） | 828 | US$502.71 | US$416,243.88 | 19,131 | SEC |
| 2026-07-01 2026-07-06 | RARE Ultragenyx Pharmaceutical Inc. | Horn Howard Officer · Chief Financial Officer | 卖出（S） | 4,698 | US$33.13 | US$155,644.74 | 100,991 | SEC |
| 2026-07-01 2026-07-06 | JAZZ Jazz Pharmaceuticals plc | COZADD BRUCE C Director | 卖出（S） | 6,000 | US$240.47 | US$144.28万 | 366,682 | SEC |
| 2026-07-01 2026-07-06 | LGND LIGAND PHARMACEUTICALS INC | Reardon Andrew Officer · CLO & Secretary | 卖出（S） | 396 | US$308.99 | US$122,359.49 | 46,118 | SEC |
| 2026-07-01 2026-07-06 | LGND LIGAND PHARMACEUTICALS INC | Reardon Andrew Officer · CLO & Secretary | 卖出（S） | 104 | US$310.20 | US$32,261.04 | 46,014 | SEC |
| 2026-07-01 2026-07-06 | LGND LIGAND PHARMACEUTICALS INC | Reardon Andrew Officer · CLO & Secretary | 卖出（S） | 1,119 | US$311.72 | US$348,814.68 | 44,895 | SEC |
| 2026-07-01 2026-07-06 | LGND LIGAND PHARMACEUTICALS INC | Reardon Andrew Officer · CLO & Secretary | 卖出（S） | 1,081 | US$312.28 | US$337,572.95 | 43,814 | SEC |
| 2026-07-01 2026-07-06 | LGND LIGAND PHARMACEUTICALS INC | Reardon Andrew Officer · CLO & Secretary | 卖出（S） | 700 | US$313.46 | US$219,420.18 | 43,114 | SEC |
| 2026-07-01 2026-07-06 | LGND LIGAND PHARMACEUTICALS INC | Reardon Andrew Officer · CLO & Secretary | 卖出（S） | 100 | US$314.58 | US$31,457.88 | 43,014 | SEC |
| 2026-07-01 2026-07-06 | LGND LIGAND PHARMACEUTICALS INC | Reardon Andrew Officer · CLO & Secretary | 卖出（S） | 900 | US$315.78 | US$284,199.75 | 42,114 | SEC |
| 2026-07-01 2026-07-06 | LGND LIGAND PHARMACEUTICALS INC | Reardon Andrew Officer · CLO & Secretary | 卖出（S） | 600 | US$317.15 | US$190,291.02 | 41,514 | SEC |
| 2026-07-01 2026-07-02 | ORMP ORAMED PHARMACEUTICALS INC. | Gabay Avraham Officer · Chief Financial Officer | 卖出（S） | 73,360 | US$4.51 | US$330,743.56 | 671,785 | SEC |
| 2026-07-01 2026-07-02 | ORMP ORAMED PHARMACEUTICALS INC. | Hexter Joshua Officer · COO & CBO | 卖出（S） | 137,000 | US$4.46 | US$611,431.00 | 1,023,384 | SEC |
| 2026-07-01 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 3,946 | US$1.55 | US$6,116.30 | 722,935 | SEC |
| 2026-07-01 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 3,946 | US$1.55 | US$6,116.30 | 722,935 | SEC |
| 2026-07-01 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 3,946 | US$1.55 | US$6,116.30 | 722,935 | SEC |
| 2026-07-01 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 3,946 | US$1.55 | US$6,116.30 | 722,935 | SEC |
| 2026-07-01 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 398 | US$1.55 | US$616.90 | 72,988 | SEC |
| 2026-07-01 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 398 | US$1.55 | US$616.90 | 72,988 | SEC |
| 2026-07-01 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 398 | US$1.55 | US$616.90 | 72,988 | SEC |
| 2026-07-01 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 398 | US$1.55 | US$616.90 | 72,988 | SEC |
| 2026-07-01 2026-07-02 | AGIO AGIOS PHARMACEUTICALS, INC. | Gheuens Sarah Officer · Chief Medical Officer | 卖出（S） | 4,007 | US$37.56 | US$150,502.92 | 84,645 | SEC |
| 2026-07-01 2026-07-02 | FENC FENNEC PHARMACEUTICALS INC. | Raykov Rosty Other | 卖出（S） | 9,599 | US$10.41 | US$99,925.59 | 138,855 | SEC |
| 2026-07-01 2026-07-02 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | HRT FINANCIAL LP TenPercentOwner | 买入（P） | 3,959 | US$3.30 | US$13,064.70 | 82,556 | SEC |
| 2026-07-01 2026-07-02 | PFSI PennyMac Financial Services, Inc. | Hendry Gregory L Officer · MD, Chief Accounting Officer | 卖出（S） | 2,177 | US$86.89 | US$189,159.53 | 48,968 | SEC |
| 2026-07-01 2026-07-02 | MIRM Mirum Pharmaceuticals, Inc. | Howe Jolanda Officer · SVP, GLOBAL CONTROLLER | 卖出（S） | 2,721 | US$120.00 | US$326,520.00 | 3,114 | SEC |
| 2026-07-01 2026-07-01 | PCSA Processa Pharmaceuticals, Inc. | Ng George K Director,Officer · Chief Executive Officer | 买入（P） | 3,057 | US$1.93 | US$5,900.01 | 15,492 | SEC |
| 2026-06-30 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 545 | US$1.54 | US$839.30 | 718,989 | SEC |
| 2026-06-30 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 545 | US$1.54 | US$839.30 | 718,989 | SEC |
| 2026-06-30 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 545 | US$1.54 | US$839.30 | 718,989 | SEC |
| 2026-06-30 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 545 | US$1.54 | US$839.30 | 718,989 | SEC |
| 2026-06-30 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 55 | US$1.54 | US$84.70 | 72,590 | SEC |
| 2026-06-30 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 55 | US$1.54 | US$84.70 | 72,590 | SEC |
| 2026-06-30 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 55 | US$1.54 | US$84.70 | 72,590 | SEC |
| 2026-06-30 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 55 | US$1.54 | US$84.70 | 72,590 | SEC |
| 2026-06-30 2026-07-01 | PCSA Processa Pharmaceuticals, Inc. | Young David Director,Officer · Pres. Research & Development | 买入（P） | 2,531 | US$1.93 | US$4,884.83 | 21,729 | SEC |
| 2026-06-30 2026-07-01 | PCSA Processa Pharmaceuticals, Inc. | SKIBSTED RUSSELL Officer · Chief Financial Officer | 买入（P） | 3,277 | US$1.93 | US$6,324.61 | 16,689 | SEC |
| 2026-06-30 2026-07-01 | PCSA Processa Pharmaceuticals, Inc. | Lin Patrick Officer · Chief Business - Strategy Off | 买入（P） | 2,106 | US$1.93 | US$4,064.58 | 13,113 | SEC |
| 2026-06-30 2026-07-01 | PCSA Processa Pharmaceuticals, Inc. | Guy Wendy Officer · Chief Administrative Officer | 买入（P） | 2,436 | US$1.93 | US$4,701.48 | 14,394 | SEC |
| 2026-06-30 2026-07-01 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | HRT FINANCIAL LP TenPercentOwner | 买入（P） | 6,755 | US$3.23 | US$21,818.65 | 78,597 | SEC |
| 2026-06-30 2026-07-01 | XFOR X4 Pharmaceuticals, Inc | KIRSKE DAVID Officer · Chief Financial Officer | 卖出（S） | 8,543 | US$4.26 | US$36,428.21 | 167,750 | SEC |
| 2026-06-29 2026-07-01 | ADIL ADIAL PHARMACEUTICALS, INC. | Coastlands Capital LP TenPercentOwner | 买入（P） | 25,000 | US$2.60 | US$65,000.00 | 373,322 | SEC |
| 2026-06-29 2026-07-01 | LUNR Intuitive Machines, Inc. | Ghaffarian Kamal Seyed Director,TenPercentOwner | 卖出（S） | 94,899 | US$20.24 | US$192.1万 | 3,541,778 | SEC |
| 2026-06-29 2026-07-01 | LUNR Intuitive Machines, Inc. | Ghaffarian Enterprises, LLC TenPercentOwner | 卖出（S） | 94,899 | US$20.24 | US$192.1万 | 3,541,778 | SEC |
| 2026-06-29 2026-07-01 | LUNR Intuitive Machines, Inc. | GM Enterprises, LLC TenPercentOwner | 卖出（S） | 94,899 | US$20.24 | US$192.1万 | 3,541,778 | SEC |
| 2026-06-29 2026-07-01 | LUNR Intuitive Machines, Inc. | Ghaffarian Kamal Seyed Director,TenPercentOwner | 卖出（S） | 47,010 | US$20.80 | US$977,892.62 | 3,494,768 | SEC |
| 2026-06-29 2026-07-01 | LUNR Intuitive Machines, Inc. | Ghaffarian Enterprises, LLC TenPercentOwner | 卖出（S） | 47,010 | US$20.80 | US$977,892.62 | 3,494,768 | SEC |
| 2026-06-29 2026-07-01 | LUNR Intuitive Machines, Inc. | GM Enterprises, LLC TenPercentOwner | 卖出（S） | 47,010 | US$20.80 | US$977,892.62 | 3,494,768 | SEC |
| 2026-06-29 2026-07-01 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | HRT FINANCIAL LP TenPercentOwner | 买入（P） | 25,836 | US$3.44 | US$88,875.84 | 71,842 | SEC |
| 2026-06-29 2026-06-30 | ANIP ANI PHARMACEUTICALS INC | CAREY STEPHEN P. Officer · SVP & CFO | 卖出（S） | 2,850 | US$84.12 | US$239,742.00 | 177,543 | SEC |
| 2026-06-26 2026-06-30 | IONS IONIS PHARMACEUTICALS INC | Schneider Eugene Officer · EVP, Chf Clinical Develop Ofcr | 卖出（S） | 26,000 | US$81.05 | US$210.73万 | 77,114 | SEC |
| 2026-06-26 2026-06-30 | IONS IONIS PHARMACEUTICALS INC | O'NEIL PATRICK R. Officer · EVP CLO & General Counsel | 卖出（S） | 3,069 | US$80.00 | US$245,520.00 | 61,470 | SEC |
| 2026-06-26 2026-06-30 | IONS IONIS PHARMACEUTICALS INC | Baroldi Joseph Officer · EVP, Chief Business Officer | 卖出（S） | 5,635 | US$80.16 | US$451,701.60 | 4,669 | SEC |
| 2026-06-26 2026-06-30 | VRTX VERTEX PHARMACEUTICALS INC / MA | Bozic Carmen Officer · EVP and CMO | 卖出（S） | 596 | US$482.50 | US$287,570.00 | 15,337 | SEC |
| 2026-06-26 2026-06-29 | PHIO Phio Pharmaceuticals Corp. | Bitterman Robert J Director,Officer · Chairman, Pres. & CEO | 买入（P） | 10,000 | US$0.99 | US$9,900.00 | 421,421 | SEC |
| 2026-06-26 2026-06-29 | ACAD ACADIA PHARMACEUTICALS INC | Kihara James Officer · PRINCIPAL ACCOUNTING OFFICER | 卖出（S） | 11,421 | US$26.08 | US$297,859.68 | 13,088 | SEC |
| 2026-06-26 2026-06-26 | IONS IONIS PHARMACEUTICALS INC | Monia Brett P Director,Officer · Chief Executive Officer | 卖出（S） | 50,000 | US$80.59 | US$402.95万 | 245,571 | SEC |
| 2026-06-25 2026-06-29 | MTSI MACOM Technology Solutions Holdings, Inc. | Hwang Donghyun Thomas Officer · SVP, Global Sales | 卖出（S） | 420 | US$382.04 | US$160,456.80 | 31,456 | SEC |
| 2026-06-25 2026-06-29 | MTSI MACOM Technology Solutions Holdings, Inc. | Hwang Donghyun Thomas Officer · SVP, Global Sales | 卖出（S） | 300 | US$382.91 | US$114,873.00 | 31,156 | SEC |
| 2026-06-25 2026-06-29 | MTSI MACOM Technology Solutions Holdings, Inc. | Hwang Donghyun Thomas Officer · SVP, Global Sales | 卖出（S） | 9 | US$384.35 | US$3,459.15 | 31,147 | SEC |
| 2026-06-25 2026-06-29 | MTSI MACOM Technology Solutions Holdings, Inc. | Hwang Donghyun Thomas Officer · SVP, Global Sales | 卖出（S） | 400 | US$386.62 | US$154,648.00 | 30,747 | SEC |
| 2026-06-25 2026-06-29 | MTSI MACOM Technology Solutions Holdings, Inc. | Hwang Donghyun Thomas Officer · SVP, Global Sales | 卖出（S） | 200 | US$387.25 | US$77,450.00 | 30,547 | SEC |
| 2026-06-25 2026-06-29 | MTSI MACOM Technology Solutions Holdings, Inc. | Hwang Donghyun Thomas Officer · SVP, Global Sales | 卖出（S） | 400 | US$388.65 | US$155,460.00 | 30,147 | SEC |
| 2026-06-25 2026-06-29 | MTSI MACOM Technology Solutions Holdings, Inc. | Hwang Donghyun Thomas Officer · SVP, Global Sales | 卖出（S） | 291 | US$389.74 | US$113,414.34 | 29,856 | SEC |
| 2026-06-25 2026-06-29 | MTSI MACOM Technology Solutions Holdings, Inc. | Hwang Donghyun Thomas Officer · SVP, Global Sales | 卖出（S） | 100 | US$391.94 | US$39,194.00 | 29,756 | SEC |
| 2026-06-25 2026-06-29 | MTSI MACOM Technology Solutions Holdings, Inc. | Hwang Donghyun Thomas Officer · SVP, Global Sales | 卖出（S） | 100 | US$379.80 | US$37,980.00 | 31,876 | SEC |
| 2026-06-25 2026-06-29 | MTSI MACOM Technology Solutions Holdings, Inc. | Hwang Donghyun Thomas Officer · SVP, Global Sales | 卖出（S） | 200 | US$375.34 | US$75,068.00 | 31,976 | SEC |
| 2026-06-25 2026-06-29 | MTSI MACOM Technology Solutions Holdings, Inc. | Hwang Donghyun Thomas Officer · SVP, Global Sales | 卖出（S） | 100 | US$367.30 | US$36,730.00 | 32,276 | SEC |
| 2026-06-25 2026-06-29 | MTSI MACOM Technology Solutions Holdings, Inc. | Hwang Donghyun Thomas Officer · SVP, Global Sales | 卖出（S） | 100 | US$369.99 | US$36,999.00 | 32,176 | SEC |
| 2026-06-25 2026-06-26 | M Macy's, Inc. | Griscom Paul Officer · SVP and Controller | 卖出（S） | 10,077 | US$25.63 | US$258,273.51 | 25,373 | SEC |
| 2026-06-25 2026-06-26 | IONS IONIS PHARMACEUTICALS INC | Swayze Eric Officer · EVP Research | 卖出（S） | 10,602 | US$79.18 | US$839,466.36 | 21,759 | SEC |
| 2026-06-25 2026-06-26 | IONS IONIS PHARMACEUTICALS INC | Monia Brett P Director,Officer · Chief Executive Officer | 卖出（S） | 21,072 | US$78.49 | US$165.39万 | 245,571 | SEC |
| 2026-06-24 2026-06-26 | IONS IONIS PHARMACEUTICALS INC | Monia Brett P Director,Officer · Chief Executive Officer | 卖出（S） | 14,565 | US$78.41 | US$114.2万 | 245,571 | SEC |
| 2026-06-24 2026-06-24 | CNTA Centessa Pharmaceuticals plc | INDEX VENTURES LIFE VI (JERSEY) L.P. TenPercentOwner | 卖出（S） | 149,421 | US$0.00 | US$0.00 | 0 | SEC |
| 2026-06-24 2026-06-24 | CNTA Centessa Pharmaceuticals plc | Yucca (Jersey) SLP TenPercentOwner | 卖出（S） | 149,421 | US$0.00 | US$0.00 | 0 | SEC |
| 2026-06-24 2026-06-24 | CNTA Centessa Pharmaceuticals plc | Index Venture Life Associates VI Ltd TenPercentOwner | 卖出（S） | 149,421 | US$0.00 | US$0.00 | 0 | SEC |
| 2026-06-24 2026-06-24 | CNTA Centessa Pharmaceuticals plc | INDEX VENTURES LIFE VI (JERSEY) L.P. TenPercentOwner | 卖出（S） | 9,812,368 | US$0.00 | US$0.00 | 0 | SEC |
| 2026-06-24 2026-06-24 | CNTA Centessa Pharmaceuticals plc | Yucca (Jersey) SLP TenPercentOwner | 卖出（S） | 9,812,368 | US$0.00 | US$0.00 | 0 | SEC |
| 2026-06-24 2026-06-24 | CNTA Centessa Pharmaceuticals plc | Index Venture Life Associates VI Ltd TenPercentOwner | 卖出（S） | 9,812,368 | US$0.00 | US$0.00 | 0 | SEC |
| 2026-06-24 2026-06-24 | CNTA Centessa Pharmaceuticals plc | Medicxi Ventures Management (Jersey) Ltd TenPercentOwner | 卖出（S） | 93,526 | US$0.00 | US$0.00 | 0 | SEC |
| 2026-06-24 2026-06-24 | CNTA Centessa Pharmaceuticals plc | Medicxi Co-Invest I LP TenPercentOwner | 卖出（S） | 93,526 | US$0.00 | US$0.00 | 0 | SEC |
| 2026-06-24 2026-06-24 | CNTA Centessa Pharmaceuticals plc | Medicxi Growth I LP TenPercentOwner | 卖出（S） | 93,526 | US$0.00 | US$0.00 | 0 | SEC |
| 2026-06-24 2026-06-24 | CNTA Centessa Pharmaceuticals plc | Medicxi Secondary I LP TenPercentOwner | 卖出（S） | 93,526 | US$0.00 | US$0.00 | 0 | SEC |
| 2026-06-24 2026-06-24 | CNTA Centessa Pharmaceuticals plc | Medicxi Ventures I GP Ltd TenPercentOwner | 卖出（S） | 93,526 | US$0.00 | US$0.00 | 0 | SEC |
| 2026-06-24 2026-06-24 | CNTA Centessa Pharmaceuticals plc | Medicxi Secondary I GP Ltd. TenPercentOwner | 卖出（S） | 93,526 | US$0.00 | US$0.00 | 0 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| FMACR | 1 | 0 | 1 | 100.00% | Q |
| MACI | 1 | 0 | 1 | 100.00% | Q |
| DMAC | 12,807.1565 | 0 | 18,885.671 | 67.81% | Q, N |
| UMAC | 810,236.0663 | 4,785 | 1,382,787.9379 | 58.59% | B, Q, N |
| MAC | 940,029.7237 | 155 | 1,612,058.1086 | 58.31% | B, Q, N |
| FMAC | 310 | 0 | 1,918 | 16.16% | Q |
| AMACU | 1,044 | 0 | 151,244 | 0.69% | Q |